CVE-2021-26726

moderate-risk
Published 2022-02-16

A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.

Do I need to act?

~
1.1% chance of exploitation in next 30 days
EPSS score — moderate exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
8
CVSS 8.8/10 High
ADJACENT_NETWORK / LOW complexity

Affected Products (1)

Dna

Affected Vendors

Valmet

References (4)

Third Party Advisory https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/
Vendor Advisory https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisories...
Third Party Advisory https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/
Vendor Advisory https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisories...
35
/ 100
moderate-risk
Severity 27/34 · High
Exploitability 3/34 · Minimal
Exposure 5/34 · Minimal